| Literature DB >> 29051455 |
Abstract
Among the halogenated hydrocarbons, chloromethanes (i.e., methyl chloride, CH₃Cl; methylene chloride, CH₂Cl₂; chloroform, CHCl₃; and carbon tetrachloride, CCl₄) play a vital role due to their extensive uses as solvents and chemical intermediates. This article aims to review their main chemical/physical properties and commercial/industrial uses, as well as the environment and health hazards posed by them and their toxic decomposition products. The environmental properties (including atmospheric lifetime, radiative efficiency, ozone depletion potential, global warming potential, photochemical ozone creation potential, and surface mixing ratio) of these chlorinated methanes are also reviewed. In addition, this paper further discusses their atmospheric fates and human health implications because they are apt to reside in the lower atmosphere when released into the environment. According to the atmospheric degradation mechanism, their toxic degradation products in the troposphere include hydrogen chloride (HCl), carbon monoxide (CO), chlorine (Cl₂), formyl chloride (HCOCl), carbonyl chloride (COCl₂), and hydrogen peroxide (H₂O₂). Among them, COCl₂ (also called phosgene) is a powerful irritating gas, which is easily hydrolyzed or thermally decomposed to form hydrogen chloride.Entities:
Keywords: atmospheric degradation; chloromethanes; environmental exposure risk; environmental property; toxicity
Year: 2017 PMID: 29051455 PMCID: PMC5750551 DOI: 10.3390/toxics5040023
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Identification and physical properties of chloromethanes.
| Property | Units | CH3Cl | CH2Cl2 | CHCl3 | CCl4 |
|---|---|---|---|---|---|
| IUPAC name | — | Chloromethane | Dichloromethane | Trichloromethane | Tetrachloromethane |
| Common name | — | Methyl chloride | Methylene chloride | Chloroform | Carbon tetrachloride |
| CAS number | — | 74-87-3 | 75-09-2 | 67-66-3 | 56-23-5 |
| Molecular weight | g/mol | 50.5 | 84.9 | 119.4 | 153.8 |
| Relative vapor density (air = 1) | -- | 1.75 | 2.93 | 4.12 | 5.32 |
| Boiling point at 1 atm | °C | −23.7 | 39.8 | 61.3 | 76.6 |
| Freezing point at 1 atm | °C | −97.7 | −96.7 | −63.5 | −22.8 |
| Critical temperature | °C | 143.1 | 237.0 | 263.4 | 283.3 |
| Critical pressure | MPa | 6.679 | 6.171 | 5.500 | 4.557 |
| Critical density | kg/m3 | 353 | 472 | 500 | 558 |
| Dipole | Debye | 1.9 | 1.8 | 1.1 | 0.0 |
| Density 20 °C | g/cm3 | 0.997 (−24 °C) | 1.322 | 1.490 | 1.595 |
| Viscosity (20 °C) | mPa.s | 0.106 (gas) | 0.430 | 0.563 | 0.965 |
| Vapor pressure (20 °C) | kPa | 506.1 | 46.5 | 21.3 | 11.9 |
| Refractive index (20 °C) | — | 1.3712 (−23.7 °C) | 1.4244 | 1.4467 | 1.4631 |
| Latent heat of vaporization at b.p. | kJ/kg | 424.1 | 330.0 | 247.0 | 194.7 |
| Log Pow (20 °C) | g/mol | 0.91 | 1.25 | 1.97 | 2.83 |
| Water solubility (20 °C) | mg/L | 6310 | 13,000 | 7950 | 805 |
| Henry’s Law constant (25 °C) | atm-m3/mol | 0.024 | 0.00268 | 0.00435 | 0.0302 |
| Flammability limits | Vol % | 8.1–17.4 | 14-25 | -- | -- |
Hazards of chloromethanes to human health.
| Compound | NIOSH a | TLV Basis- Critical Effect b | |
|---|---|---|---|
| Exposure Routes | Target Organs | ||
| CH3Cl | Inhalation, skin and/or eye contact (liquid) | Central nervous system (CNS), liver, kidneys, reproductive system | CNS impair; liver, kidney, and testicular damage; teratogenic effects |
| CH2Cl2 | Inhalation, skin absorption, ingestion, skin and/or eye contact | Eyes, skin, cardiovascular system, CNS | COHb-emia; CNS impair |
| CHCl3 | Inhalation, skin absorption, ingestion, skin and/or eye contact | Liver, kidneys, heart, eyes, skin, CNS | Liver and embryo/fetal damage; CNS impair |
| CCl4 | Inhalation, skin absorption, ingestion, skin and/or eye contact | CNS, eyes, lung, liver, kidneys, skin | Liver damage |
a The data are from [26]; b The data are from [27].
Occupational exposure limits of chloromethanes.
| Compound | Exposure Limits | ||||
|---|---|---|---|---|---|
| TLV a | PEL b | IDLH c | MAK d | PCS e | |
| CH3Cl | 50 ppm | 100 ppm | 2000 ppm | 50 ppm | 50 ppm |
| CH2Cl2 | 50 ppm | 25 ppm | 2300 ppm | 50 ppm | 50 ppm |
| CHCl3 | 10 ppm | 50 ppm (Ceiling) | 500 ppm | 0.5 ppm | 10 ppm (Ceiling) |
| CCl4 | 0.1 ppm | 10 ppm | 200 ppm | 0.5 ppm | 2 ppm |
a Threshold limit value (ACGIH, Cincinnati, OH, USA); b Permissible exposure limit (OSHA, Washington, DC, USA); c Immediately dangerous to life or health (NIOSH, Washington, DC, USA); d Maximum concentrations at the workplace (DFG, Bonn, Germany); e Permissible exposure limit (OSHA, Taipei, Taiwan).
Carcinogenicity classification of chloromethanes.
| Compound | Carcinogenicity Classification/Category | ||||
|---|---|---|---|---|---|
| IARC | UN EPA | US NTP | ACGIH | DFG | |
| CH3Cl | 3 | -- a | -- a | -- | 3B |
| CH2Cl2 | 2A | likely to be carcinogenic | Reasonably anticipated to be human carcinogens | A3 | 5 |
| CHCl3 | 2B | likely to be carcinogenic | Reasonably anticipated to be human carcinogens | A3 | 4 |
| CCl4 | 2B | likely to be carcinogenic | Reasonably anticipated to be human carcinogens | A2 | 4 |
a Not available.
Environmental properties of chloromethanes.
| Compound | Atmos. Lifetime a (yr) | Radiative Efficiency b (W m−2 ppb−1) | GWP c | ODP d | POCP e | Surface Mixing Ratio f (ppt) |
|---|---|---|---|---|---|---|
| CH3Cl | 1.0 | 0.01 | 12 | 0.02 | 1 | 530–560 |
| CH2Cl2 | 0.4 | 0.03 | 9 | ≈0.0 | 3 | 20–60 |
| CHCl3 | 0.4 | 0.08 | 16 | ≈0.0 | ≈0 | 10–20 |
| CCl4 | 33.0 | 0.17 | 1730 | 1.1 | 0 | 80–90 |
a Source [33]; b Source [33,34]; c Global warming potential with a 100-year time horizon (relative to GWP of CO2 = 1.0); source [33]; d Ozone depletion potential (relative to the ODP of CFC-11 = 1.0); source [13,32]; e Photochemical ozone creation potential (relative to POCP of ethene = 100); source [31]; f Source [13,30,32].
Hazards of degradation products of chloromethanes to human health.
| Degradation Products | UN NIOSH a | TLV Basis- Critical Effect b | |
|---|---|---|---|
| Exposure Routes | Target Organs | (TLV) | |
| Cl2 | Inhalation, skin and/or eye contact | Eyes, skin, respiratory system | Upper respiratory tract (URT) and eye irritation (0.5 ppm-TWA) |
| HCl | Inhalation, skin and/or eye contact, ingestion (solution) | Eyes, skin, respiratory system | URT irritation (2 ppm-ceiling) |
| COCl2 | Inhalation, skin and/or eye contact (liquid) | Eyes, skin, respiratory system | URT irritation; pulmonary edema (0.1 ppm-TWA) |
| CO | Inhalation, skin and/or eye contact (liquid) | Cardiovascular system, lungs, blood, central nervous system | COHb-emia (25 ppm) |
| CO2 | Inhalation, skin and/or eye contact (liquid/solid) | Respiratory system, cardiovascular system | Asphyxia (5000 ppm) |
| H2O2 | Inhalation, skin and/or eye contact | Eyes, skin, respiratory system | Eye, URT, and skin irritation (1 ppm) |
a The data are from [26]; b The data are from [27].